Measurement of adherence to antiretroviral medications

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue SUPPL. 3, 2002, Pages

  Paterson, David L ^a   Potoski, Brian ^a   Capitano, Blair ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adherence; Compliance; Electronic monitoring; HIV

Indexed keywords

ANTIRETROVIRUS AGENT;

CONFERENCE PAPER; DEVICE; ELECTRONICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS BEHAVIOR; INTERMETHOD COMPARISON; MEASUREMENT; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; STANDARD; TIME;

EID: 0037114894     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212153-00003     Document Type: Conference Paper

References (18)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
2. Duong M, Piroth L, Peytavin G, et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response. Clin Infect Dis 2001;33:386-92.
3. Richardson D, Liou SH, Kahn JO. Uric acid and didanosine compliance in AIDS clinical trials: An analysis of AIDS Clinical Trials Group protocols 116A and 116B/117. J Acquir Immune Defic Syndr 1993;6:1212-23.
4. Vergis EN, Paterson DL, Wagener MM, et al. Dyslipidaemia in HIV-infected patients: Association with adherence to potent antiretroviral therapy. Int J STD AIDS 2001;12:463-8.
5. Kastrissios H, Suarez JR, Hammer S, et al. The extent of nonadherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS 1998;12:2305-11.
6. Lorenzi P, Yerly S, Abderrakim K, et al. Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study. AIDS 1997;11:F95-9.
7. Murri R, Ammassari A, De Luca A, et al. Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients. Lancet 1999;353:1974.
8. Acosta EP, Gerber JG. Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res Hum Retroviruses 2002; 18:825-34.
9. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:435-42.
10. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-30.
11. Turner BJ, Hecht FM. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 2001;134:1004-6.
12. Duong M, Piroth L, Grappin M, et al. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. HIV Clin Trials 2001;2:128-35.
13. Bangsberg DR, Bronstone A, Hofmann R. A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care 2002;14:3-15.
14. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77.
15. Murri R, Ammassari A, Gallicano K, et al. Patient reported nonadherence with HAART is related to protease inhibitor level. J Acquir Immune Defic Syndr 2000;24:123-8.
16. Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976;1: 1265-8.
17. Parienti JJ, Verdon R, Bazin C, et al. The pills identification test: A tool to assess adherence to antiretroviral therapy. JAMA 2001; 285:412.
18. Bangsberg DR, Hecht FM, Charlebois ED, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS Behav 2001;5:275-81.